載入...
Pharmacokinetics and tolerability of multiple-dose rosuvastatin: An open-label, randomized-sequence, three-way crossover trial in healthy Chinese volunteers
Background: Rosuvastatin has been reported to be beneficial in the treatment of dyslipidemia. The C(max) and AUC(0−t) of rosuvastatin were reported to be ~2 to 4 times higher in Chinese subjects compared with white subjects after administration of a single 1-mg/kg dose. Objectives: The aims of this...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3967345/ https://ncbi.nlm.nih.gov/pubmed/24683247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2009.10.004 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|